Ivermectin in rosacea

NICE has issued advice on the use of ivermectin cream for inflammatory lesions in papulopustular rosacea

In two RCTs, ivermectin 10mg/g cream was statistically significantly more effective than vehicle cream (placebo) in improving rosacea severity score and reducing inflammatory lesion count. 

In another RCT, ivermectin was superior to metronidazole cream at reducing lesion count and improving rosacea severity score, with study participants having about 10% fewer lesions. Local adverse events, including skin irritation, pruritus and dry skin, are common, although these are mostly transient, and mild to moderate in severity. 

More than two-thirds of patients using ivermectin rated their improvement as ‘excellent’ or ‘good’, compared with about one-third of people in the vehicle group.

ESNM68. London, NICE, January 2016

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Two new steroid inhalers launched

Two new steroid inhalers launched

A new beclometasone metered-dose inhaler and a new...

Half of patients on statins do not reach cholesterol goals, study shows

Half of patients on statins do not reach cholesterol goals, study shows

Half of patients prescribed statins fail to reach their...

First oral hypoglycaemic licensed for add-on therapy in type I diabetes

First oral hypoglycaemic licensed for add-on therapy in type I diabetes

The SGLT2 inhibitor dapagliflozin (Forxiga) can now...

Quick-reference MIMS COPD prescribing resources updated

Quick-reference MIMS COPD prescribing resources updated

Concise MIMS resources on COPD management and antibiotic...